Trials / Sponsors / Iterion Therapeutics
Iterion Therapeutics
Industry · 2 registered clinical trials — 1 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Recruiting | A Study of Tegavivint (BC2059) in Patients With Advanced Hepatocellular Carcinoma Advanced Hepatocellular Carcinoma | Phase 1 / Phase 2 | 2023-09-13 |
| Completed | Phase I, Open-label, Non-randomized Study to Evaluate Safety of BC2059 Desmoid Tumor | Phase 1 | 2018-07-15 |